Several biochemical pathways are followed for the management of AD but one of the most established approach is the inhibition of acetylcholinesterase (AChE) (Zeb et al., 2014; Ahmad et al., 2015; Kamal et al., 2015; Sadiq et al., 2015). This evidence concerns the gene ACHE and Alzheimer disease.